Articles published by Lumos Pharma, Inc.
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024
October 30, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
September 05, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
August 15, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
August 01, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
June 04, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
April 18, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
March 07, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
February 26, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
February 05, 2024
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
November 20, 2023
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
November 07, 2023
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Announces Participation in Investor Conferences in September
September 07, 2023
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
August 09, 2023
From Lumos Pharma, Inc.
Via GlobeNewswire
Tickers
LUMO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.